Eisai to Acquire Global License to ChemAxon Software for Drug Discovery Infrastructure

Eisai to Acquire Global License to ChemAxon Software for Drug Discovery Infrastructure

January 03, 2012

BUDAPEST, Hungary, & TOKYO--(BUSINESS WIRE)--Patcore, Inc., an exclusive agency for ChemAxon in Japan, confirms the global licensing of ChemAxon's JChem Cartridge for Oracle to Eisai Co. The database storage and search technology will be used by Eisai for the management of chemical structure information generated in discovery processes in Eisai's global R&D organization. Simultaneously, the current structure compound control checking system "CRAIS Checker", developed by Patcore, which is used in Eisai's domestic research laboratories, will also be deployed globally.

About JChem Cartridge for ORACLE

JChem Cartridge for Oracle was developed by ChemAxon, a leading provider of platform toolkits for chemical structure handling, and adds chemical knowledge to the Oracle platform. Compared to similar technologies ChemAxon's JChem Cartridge for Oracle provides faster performance, increased accuracy and support for more chemical structure information standards.

About CRAIS Checker

CRAIS Checker is a system to evaluate whether a given compound is a controlled substance, based on chemical structure. Pharmaceutical R&D routinely uses very large numbers of compounds which need to be handled in compliance with current laws and regulations; however detection of the controlled substance is not straightforward. CRAIS Checker enables users to correctly identify controlled substances more efficiently and confidently. CRAIS Checker has been adopted by the majority of Japanese pharmaceutical companies.

About Eisai

Eisai is one of the world's leading R&D-based pharmaceutical companies. For further information please visit our web site http://www.eisai.com.

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. The company is privately owned with European headquarters in Budapest and sales and support offices in Europe, Japan and North America. For further information please visit our web site http://www.chemaxon.com.

About Patcore

Patcore Inc. is a Japan-based informatics services company for life science research. The company provides cheminformatics products and services to enable its customers to accelerate their research and discover new products faster. With extensive knowledge of informatics strategy and research processes, Patcore facilitates better decision making for pharmaceutical, biotechnology, agrochemical, and chemical researchers. For further information please visit our web site http://www.patcore.com.

Contacts

ChemAxon Ltd.
Alex Allardyce, +361-453-0435
[email protected]
www.chemaxon.com

 

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.